Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€146.15
15.07.22
€155.00
15.07.23
5.64%
23.07.22

Could be very worthwhile Investment >20% year
Innovative
Sustainability is important
Small cyclical dependencies
buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€146.15
15.07.22
€175.00
15.07.23
21.16%
16.07.23

buy
Carmat

Start price
Target price
Perf. (%)
€14.84
30.03.22
€18.00
30.03.23
-17.45%
22.10.22

Could be worthwhile Investment >10% per year
buy
Sartorius Stedim Biotech S.A.

Start price
Target price
Perf. (%)
€328.00
20.02.22
€400.00
20.02.23
1.01%
21.02.23

Could be worthwhile Investment >10% per year
Orpea Nom.

Start price
Target price
Perf. (%)
€36.36
19.02.22
€32.00
19.02.23
-5.42%
05.03.22

Risky Investment
Orpea Nom.

Start price
Target price
Perf. (%)
€34.38
06.02.22
€31.00
06.02.23
5.76%
19.02.22

Risky Investment
buy
Visiomed Group

Start price
Target price
Perf. (%)
€0.17
24.01.22
-
24.01.23
116.40%
25.01.23

Could be worthwhile Investment >10% per year
Edap Tms S.A. ADR

Start price
Target price
Perf. (%)
€5.00
03.01.22
-
03.01.23
27.00%
15.05.22

Probably not worthwhile Investment
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€10.64
24.12.21
-
24.12.22
-57.99%
25.12.22

Could be worthwhile Investment >10% per year
Crossject S.A.

Start price
Target price
Perf. (%)
€2.82
18.11.21
€2.50
18.11.22
66.84%
16.08.22

Could be worthwhile Investment >10% per year
buy
bioMerieux S.A.

Start price
Target price
Perf. (%)
€106.50
08.11.21
€110.00
08.11.22
-12.21%
09.11.22

Could be worthwhile Investment >10% per year
bioMerieux S.A.

Start price
Target price
Perf. (%)
€107.60
07.11.21
€100.00
07.11.22
-1.02%
08.11.21

Could be worthwhile Investment >10% per year
buy
Mauna Kea Tech

Start price
Target price
Perf. (%)
€0.84
07.11.21
€1.10
07.11.22
-33.61%
08.11.22

Could be worthwhile Investment >10% per year
buy
Biosynex

Start price
Target price
Perf. (%)
€15.66
20.10.21
€17.00
20.10.22
-21.52%
21.10.22

Could be worthwhile Investment >10% per year
buy
Korian S.A.

Start price
Target price
Perf. (%)
€28.30
17.10.21
€30.00
17.10.22
-62.44%
18.10.22

Could be worthwhile Investment >10% per year
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€101.00
28.09.21
€105.00
28.09.22
-87.18%
29.09.22

Could be worthwhile Investment >10% per year
buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€155.60
08.07.21
€195.00
08.07.22
8.64%
18.02.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
buy
Spineway

Start price
Target price
Perf. (%)
€68.00
15.06.21
-
15.06.22
-52.94%
16.02.22

Could be very worthwhile Investment >20% year
Market Leader or Top 3
buy
bioMerieux S.A.

Start price
Target price
Perf. (%)
€111.90
12.04.21
€120.00
12.04.22
-3.84%
07.11.21

Could be worthwhile Investment >10% per year
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€22.15
12.04.21
€28.35
12.04.22
-51.96%
24.12.21

Could be worthwhile Investment >10% per year
buy
Pixium Vision S.A.

Start price
Target price
Perf. (%)
€1.03
17.02.21
€3.00
17.02.22
-24.32%
25.12.21

Could be very worthwhile Investment >20% year
Leading role in innovation
Future proof or reliable business model
buy
Visiomed Group

Start price
Target price
Perf. (%)
€0.86
25.01.21
€1.00
25.01.22
-80.01%
24.01.22

Could be worthwhile Investment >10% per year
buy
Biosynex

Start price
Target price
Perf. (%)
€21.20
25.01.21
€26.00
25.01.22
-26.13%
20.10.21

Could be worthwhile Investment >10% per year
buy
Crossject S.A.

Start price
Target price
Perf. (%)
€3.67
21.01.21
€10.00
21.01.22
-28.61%
22.01.22

Could be very worthwhile Investment >20% year
buy
Bastide Le Confort

Start price
Target price
Perf. (%)
€45.70
11.10.20
€48.00
04.11.21
-7.11%
05.11.21

Could be worthwhile Investment >10% per year